Targeting MCL-1 in hematologic malignancies: Rationale and progress von Wei, Andrew H., Roberts, Andrew W., Spencer, Andrew, Rosenberg, Aaron Seth, Siegel, David, Walter, Roland B., Caenepeel, Sean, Hughes, Paul, McIver, Zach, Mezzi, Khalid, Morrow, Phuong Khanh, Stein, Anthony

Volltext

Cytopenia and leukocyte recovery shape cytokine fluctuations after myeloablative allogeneic hematopoietic stem cell transplantation von Jan Joseph Melenhorst, Xin Tian, Dihua Xu, Netanya G. Sandler, Philip Scheinberg, Angelique Biancotto, Priscila Scheinberg, John Phil McCoy, Jr, Nancy F. Hensel, Zach McIver, Daniel C Douek, Austin John Barrett

Volltext

A Phase 1, First-in-Human Study of AMG 176, a Selective MCL-1 Inhibitor, in Patients With Relapsed or Refractory Multiple Myeloma von Spencer, Andrew, Rosenberg, Aaron Seth, Jakubowiak, Andrzej, Raje, Noopur, Chatterjee, Manik, Trudel, Suzanne, Bahlis, Nizar J., Siegel, David S., Wilop, Stefan, Harrison, Simon J., NagaKrishna, Murthy, Dhuria, Shyeilla, Hindoyan, Antreas, McIver, Zach, Henary, Haby, Morrow, Phuong Khanh, Roberts, Andrew

Volltext

Impact of an oncology clinical pharmacist specialist in an outpatient multiple myeloma clinic von Virani, Amin, Schlei, Zach, Jakubowiak, Andrzej J., Jasielec, Jagoda, Gleason, Christine, Ackermann, Megan, Wolfe, Brittany, Major, Sarah, McIver, Amanda, Parsad, Sandeep

Volltext